12-52007179-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000293662.9(TAMALIN):c.160G>A(p.Glu54Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000736 in 1,358,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000293662.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAMALIN | NM_181711.4 | c.160G>A | p.Glu54Lys | missense_variant | 1/8 | ENST00000293662.9 | NP_859062.1 | |
TAMALIN | XM_047428439.1 | c.-181G>A | 5_prime_UTR_variant | 1/7 | XP_047284395.1 | |||
TAMALIN-AS1 | NR_146770.1 | n.477C>T | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAMALIN | ENST00000293662.9 | c.160G>A | p.Glu54Lys | missense_variant | 1/8 | 1 | NM_181711.4 | ENSP00000293662.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000822 AC: 1AN: 121728Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 71004
GnomAD4 exome AF: 7.36e-7 AC: 1AN: 1358762Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 673630
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.160G>A (p.E54K) alteration is located in exon 1 (coding exon 1) of the GRASP gene. This alteration results from a G to A substitution at nucleotide position 160, causing the glutamic acid (E) at amino acid position 54 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at